Bodenstedt Matthias bought MLTX
January 7, 2026 · Form 4 insider transaction
Bodenstedt Matthias bought 354,296 shares of MoonLake Immunotherapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
354,296
Price
$0.00
Total value
N/A
InsiderBodenstedt Matthias
Role—
SecurityClass A ordinary shares, par value $0.0001 per share
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after1,276,305
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of restricted stock that vest in four equal annual installments on January 7, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.